【NEX 2023】北京福纳康锁定标展

北京福纳康生物技术有限公司成立于2015年，与中科院化学研究所深度合作，是一家专注于高纯度富勒烯原料、富勒烯创新药物、富勒烯钙钛矿材料、富勒烯光触媒材料研发与生产的国家高新技术企业。公司现已建成“富勒烯创新药研发中心”、“富勒烯光触媒材料研发中心”、“富勒烯药研动物实验中心”，以及赤峰和通化两个富勒烯产业化基地，成为富勒烯研究与应用的全球领跑者。也是“富勒烯纯度测定方法”国家标准（GB/T 44241-2022）和富勒烯含量/溶残测定方法团体标准（T/CSTM 00194-2021，T/CSTM 00195-2021）的牵头制定者。

福纳康首席科学家王春儒，专注于富勒烯研究30余年，中国科学院化学研究所研究员、博士生导师，中国科学院纳米实验室副主任。全国政协委员（科技界），享受国务院特殊津贴专家，科技部重大科学研究计划首席科学家，获得国家杰出青年科学基金资助，主持国家973、863、科技部重点研发项目、科学院知识创新工程、国家重大科研仪器研制项目、国家自然科学基金委重点项目等二十余项重大项目，在Nature、Science、Sci. Adv.,、Nat. Commun.等高影响力期刊上发表论文300余篇，被他引12000多次，获得授权发明专利80余项。王春儒团队在富勒烯生物医药相关专利数量全球排名第一。

钙钛矿太阳能电池是基于钙钛矿结构活性材料的太阳能电池，属于第三代高效薄膜电池，具有高效率、低成本、高柔性等优势，是最具潜力的下一代光伏技术之一。富勒烯及其衍生物是钙钛矿电池中最为常用的电子传输材料，对提升电池的稳定性和转化效率起到了重要作用。福纳康作为国际领先的富勒烯原料制备企业，能够大量供应高纯度富勒烯（C60和C70）与功能化富勒烯（PCBM）原料，为全球清洁能源事业积极贡献一份力量。

Beijing Funacong Biotechnology Co., Ltd. was established in 2015 and has deep cooperation with the Institute of Chemistry of the Chinese Academy of Sciences. It is a national high-tech enterprise specializing in the research and production of high-purity fullerene raw materials, innovative fullerene drugs, fullerene perovskite materials, and fullerene photocatalyst materials. The company has now established the "Fullerene Innovative Drug R&D Center", "Fullerene Photocatalyst Material R&D Center", "Fullerene Pharmaceutical Research and Animal Experiment Center", as well as two Fullerene Industrialization Bases, Chifeng and Tonghua, becoming a global leader in Fullerene research and application. He is also the lead developer of the national standard for the determination of fullerene purity (GB/T 44241-2022) and the group standard for the determination of fullerene content/residue (T/CSTM 00194-2021, T/CSTM 00195-2021).

Wang Chunru, chief scientist of Funakon, has been focusing on fullerene research for more than 30 years, a researcher and doctoral supervisor of the Institute of Chemistry of the Chinese Academy of Sciences, and deputy director of the Nanolab of the Chinese Academy of Sciences. Member of the National Committee of the Chinese People's Political Consultative Conference (CPPCC), expert enjoying special allowances from the State Council, chief scientist of the Major Scientific Research Program of the Ministry of Science and Technology, supported by the National Outstanding Youth Science Foundation, and responsible for more than 20 major projects including National 973, 863, Key R&D Projects of the Ministry of Science and Technology, Knowledge Innovation Project of the Chinese Academy of Sciences, National Major Research Instrument Development Projects, and Key Projects of the National Natural Science Foundation of China More than 300 papers have been published in influential journals such as Adv., Nat. Commun., and have been cited more than 12000 times by him, obtaining over 80 authorized invention patents. Wang Chunru's team ranks first globally in the number of patents related to fullerene biopharmaceuticals.